A preliminary investigation on the efficacy and mechanism of postoperative application of Sophora granules in triple-negative breast cancer patients

试验速览

阶段: 4 期
状态: 招募中
发起方: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine

暂无简介。

•1. Patients who have undergone modified radical mastectomy or breast-conserving surgery for triple-negative breast cancer;
•2. Aged 18 and 80 years;
•3. have completed postoperative adjuvant chemotherapy and are on a first-line regimen (AT/TAC), and have not received chemotherapy or breast cancer-related medications within 1 month;
•4. do not have significant cardiopulmonary or renal insufficiency;
•5. Barthel Index score > 70.

•1. Combination of other malignant tumors, other autoimmune related diseases and endocrine diseases;
•2. Patients with unclear pathological diagnosis or those who do not meet the staging of the group to which they belong;
•3. Patients with significant cardiac, hepatic, renal, cerebral, neurological or hematopoietic dysfunction;
•4. Women who are pregnant, lactating or preparing for pregnancy;
•5. Patients with allergies or known hypersensitivity to therapeutic agents or components;
•6. Patients with known distant metastases or recurrence;
•7. Patients who are participating in other clinical drug trials;
•8. Patients with a Barthel Index score <=60 on the daily living ability scale.

发起方